Status:
COMPLETED
ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry
Lead Sponsor:
Alkermes, Inc.
Conditions:
Opioid Dependence
Eligibility:
All Genders
18+ years
Brief Summary
The objective of the VIVITROL Registry is to gather real world data on opioid dependence and to provide understanding of the health economics of opioid dependence.
Detailed Description
The VIVITROL Registry is an observational, open-label, single-arm, multi-center registry of patients who have initiated treatment with VIVITROL for prevention of relapse to opioid dependence, followin...
Eligibility Criteria
Inclusion
- Patient is aged 18 years or older
- Patient is diagnosed with a current opioid dependence for which treatment with VIVITROL is being initiated
- Patient has provided written informed consent
- Patient is willing and able to provide the information to be collected via the registry's interviews and questionnaires
- Patient expects to be available for ongoing registry participation
Exclusion
- Prior use of VIVITROL
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
403 Patients enrolled
Trial Details
Trial ID
NCT01422837
Start Date
August 1 2011
End Date
October 1 2013
Last Update
November 16 2018
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Assisted Recovery Centers of America
Phoenix, Arizona, United States, 85014
2
Arkansas Psychiatric Clinc
Little Rock, Arkansas, United States, 72223
3
Amy Solomon, MD
Ben Lomond, California, United States, 95005
4
Touchstone Medical Group
Clovis, California, United States, 93611